| 000 | 01017 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517220057.0 | ||
| 264 | 0 | _c20190718 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1557-8925 | ||
| 024 | 7 |
_a10.1016/bs.apha.2018.03.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCronin-Fenton, Deirdre P | |
| 245 | 0 | 0 |
_aTamoxifen and CYP2D6: A Controversy in Pharmacogenetics. _h[electronic resource] |
| 260 |
_bAdvances in pharmacology (San Diego, Calif.) _c2018 |
||
| 300 |
_a65-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xmetabolism |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aTamoxifen _xmetabolism |
| 700 | 1 | _aDamkier, Per | |
| 773 | 0 |
_tAdvances in pharmacology (San Diego, Calif.) _gvol. 83 _gp. 65-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/bs.apha.2018.03.001 _zAvailable from publisher's website |
| 999 |
_c28430617 _d28430617 |
||